WHO-GMP Loan-License Units (Baddi / Roorkee) UCPMP 2024 Compliant

CDSCO & State SLA Approved Formulations.
Ethical PCD Pharma Franchise & Monopoly Rights.

Havelift Healthcare Pvt. Ltd. is a West Bengal-based pharmaceutical marketing firm delivering CDSCO & State SLA-approved allopathic formulations and FSSAI nutraceuticals. Manufactured under loan licenses at WHO-GMP certified facilities in Baddi & Roorkee, sealed in cold-form Alu-Alu barrier foils, and distributed with legally stamped district monopoly agreements and 24–48h central depot dispatch.

HPLC / IP Batch Assay Validated
Alu-Alu Zone IVb Barrier Foil
24–48h Central Depot Dispatch SLA
Havelift Healthcare Commercial Blister Packaging and Monograph Formulation
ANTIBIOTIC SCH H1
Etacef-AZ
Cefixime 200mg + Azithro 250mg
TERRITORY RIGHTS STAMP DEED
District Monopoly Rights
Notarized Legal Exclusivity Deed

Statutory Trade Advisory: RMP, Stockist & Franchise Portal Only

In strict compliance with the Drugs and Cosmetics Act, 1940 & Rules 1945 (including Rule 65(17) and Rule 97), the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and the Uniform Code for Pharmaceuticals Marketing Practices (UCPMP, 2024):

  • Trade Reference Only: This portal is intended exclusively for Registered Medical Practitioners (RMPs), C&F agents, wholesale stockists holding valid Form 20B / 21B Drug Licenses and active GSTIN, and prospective PCD franchise partners. Strictly no direct-to-consumer (DTC) or retail sales.
  • Prescription Dispensing (Schedule H & H1): Formulations labeled with Rx Schedule H or Rx Schedule H1 must be dispensed strictly against the written prescription of an RMP. Schedule H1 drugs (e.g., Cefixime + Azithromycin) require mandatory 3-year record maintenance in the chemist’s Schedule H1 register.
  • DPCO 2013 & FSSAI Demarcation: Formulation pricing strictly respects NPPA ceiling prices and non-scheduled annual caps under DPCO 2013. Products designated under FSSAI Lic. No. 12120801000198 are dietary food supplements, not for medicinal use, and not intended to diagnose, treat, or prevent any illness.
CORPORATE PROFILE • REGULATORY ETHOS
PCD Pharma Operations

Ethical Marketing & Loan-License Distribution

Headquartered in West Bengal, Havelift Healthcare Pvt. Ltd. connects WHO-GMP approved loan-license manufacturing facilities in Paonta Sahib (HP) and Roorkee (UK) with authorized stockists, C&F agents, and PCD franchise associates across India.

UCPMP 2024 Ethical Detailing

001

Operating under the Department of Pharmaceuticals UCPMP 2024 code. We equip franchise field representatives with laminated spiral visual aids, LBLs, and scientific monographs. Physician samples are strictly stamped "PHYSICIAN SAMPLE - NOT FOR SALE" and capped at maximum 12 packs per RMP per annum with electronic distribution logging.

Rule 65(17) • Capped Physician Samples

WHO-GMP Loan-License Hubs

002

Allopathic solid oral dosages and prolonged-release pellets are produced under Form 28A loan licenses at Saphnix Life Sciences (WHO-GMP, Paonta Sahib/Baddi, HP). Dietary supplements are manufactured at Greenwell Biosciences (ISO & GMP, Roorkee, UK), strictly batch-tested against Indian Pharmacopoeia (IP) dissolution and assay monographs.

Saphnix (Paonta Sahib) & Greenwell (Roorkee)

District Monopoly & PTR/PTS Margins

003

Franchise partners receive legally registered district monopoly agreements on stamp paper, eliminating cross-territory price cutting. We provide transparent PTR/PTS trade margin pricing (20% retailer / 10% stockist) with 24–48h central depot dispatch via accredited pharma cargo logistics (V-Trans / Safechem).

North 24 Parganas Depot • 24–48h Dispatch

COMMERCIAL FORMULATIONS • DISPATCH PORTFOLIO
Therapeutic Portfolio

CDSCO & State SLA Commercial Formulations

Explore our ethical prescription allopathic formulations and FSSAI dietary supplements. Click image thumbnails to inspect cold-form Alu-Alu blister packaging, or open Technical Specs for monograph assays, loan-licensing provenance, and statutory prescribing information.

Etacef AZ

Tablets
001
Schedule H1
Antibacterial & Anti-infective
Active Salt / Formulation
Cefixime, Azithromycin & Lactic Acid Bacillus Tablets

Synergistic dual-antibiotic formulation combining third-generation cephalosporin and macrolide, balanced with beneficial spore probiotics to support gut microflora during intensive therapy.

  • Packaging: 10 x 1 x 10 Tablets (Alu-Alu Blister)
  • Standard: IP Monograph • Schedule H1 Register Mandatory • Cold-Form Alu-Alu

Dcoba NP

Tablets
002
Schedule H
Neurology & Neuropathic Pain
Active Salt / Formulation
Pregabalin, Methylcobalamin & Nortriptyline Tablets

Evidence-based triple formulation targeting the management of neuropathic pain and peripheral neuropathy through calcium-channel modulation, neural remyelination, and central pain modulation.

  • Packaging: 10 x 1 x 10 Tablets (Alu-Alu Strip)
  • Standard: IP Monograph • Schedule H Prescription • Alu-Alu Barrier Foil

Fanta DSR

Capsules
003
Schedule H
Gastroenterology
Active Salt / Formulation
Pantoprazole Gastro-resistant & Domperidone Prolonged-release Capsules I.P.

Dual-action gastroprokinetic and proton pump inhibitor providing sustained relief from acid reflux, GERD, and associated nausea with optimized chronotherapeutic release pellets.

  • Packaging: 10 x 10 Capsules (Alu-Alu Strip)
  • Standard: IP Dual-Pellet Technology (Enteric + PR) • Schedule H

Felo XT

Tablets
004
Schedule H
Hematinic & Nutritional
Active Salt / Formulation
Ferrous Ascorbate, Folic Acid & Zinc Sulphate Tablets

Advanced oral hematinic formulation offering high bioavailability and enhanced gastrointestinal tolerance for rapid restoration of hemoglobin and vital cellular cofactors.

  • Packaging: 10 x 1 x 10 Tablets (Alu-Alu Strip)
  • Standard: IP Hematinic Monograph • Non-Constipating Chelate • Alu-Alu

ZISAMIN-C2

Tablets
005
FSSAI Supplement
Joint Health & Mobility
Active Salt / Formulation
Glucosamine Sulfate, Chondroitin Sulfate, Collagen (Type 2), Ginger Extract, Rosehip, Vitamins & Minerals

Multi-nutrient nutraceutical formulation supporting cartilage resilience, synovial fluid lubrication, and joint mobility with standardized botanical antioxidants.

  • Packaging: 10 x 1 x 10 Tablets (Alu-Alu Blister)
  • Standard: FSSAI Cat. 13.6 Nutraceutical • Standardized Botanical Actives

DLINE-UC

Tablets
006
FSSAI Supplement
Joint Health & Mobility
Active Salt / Formulation
Undenatured Collagen Peptide (Type 2), Hyaluronic Acid, Rosehip Extract & Collagen Peptide (Type 10)

Targeted cartilage matrix dietary supplement featuring undenatured collagen peptides and high-grade hyaluronic acid to nourish joint cushion and support natural physical flexibility.

  • Packaging: 10 x 1 x 10 Tablets (Alu-Alu Strip)
  • Standard: FSSAI Nutraceutical • Intact Undenatured Collagen Type II
QUALITY ASSURANCE & ANALYTICAL STANDARDS

Revised Schedule M & IP Monograph Standards

Every commercial batch is manufactured at WHO-GMP approved facilities under validated Batch Manufacturing Records. Formulations undergo multi-point HPLC assay testing, dissolution profiling, and Zone IVb tropical stability validation before release by an approved Government Analyst.

WHO-GMP Approved Facilities
HPLC Multi-Point Assay
Zone IVb Tropical Stability
BMR Validated Records

HPLC Assay & Dissolution

001

Multi-point High-Performance Liquid Chromatography enforces strict active pharmaceutical ingredient assay limits. In-vitro dissolution testing via IP/USP Type II apparatus guarantees bio-equivalence for every released batch.

98.0%–102.0% API assay limits enforced

Alu-Alu Cold-Form Barrier

002

Heavy-gauge tri-laminate foil provides near-zero moisture vapor transmission. Validated under Zone IVb tropical stability conditions (30°C/75% RH real-time & 40°C/75% RH accelerated testing).

OPA 25µ / Al 45µ / PVC 60µ tri-laminate

Batch COA & Retained Samples

003

Batch-specific Certificate of Analysis signed by QC Heads and approved analysts accompanies every consignment. Control retention samples maintained in climate-controlled storage for 12 months beyond product expiry per Schedule M.

QC-signed COA with every consignment

PvPI Post-Marketing Surveillance

Adverse Drug Reaction (ADR) & Product Quality Reporting

In alignment with the Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) and CDSCO guidelines, Havelift Healthcare Pvt. Ltd. maintains an active Pharmacovigilance & Drug Safety Desk. Registered Medical Practitioners, pharmacists, stockists, and patients are urged to report any suspected adverse reactions, lack of efficacy, or physical packaging defects.

*All reports are logged and evaluated by our Quality Assurance cell. Quality defect complaints trigger immediate control sample re-testing within 72 hours. This channel is not for emergency clinical guidance; in case of acute medical distress, please contact your attending physician or nearest medical facility immediately.

Direct Drug Safety & QA Desk
Vigilance Email
vigilance@havelift.in
Safety Desk / Helpline
Available on request
Quality Cell Address
Havelift Healthcare Pvt. Ltd., 85, Ghola, Post Ghola Bazar, North 24 Parganas, West Bengal - 700110
Reporting Standard
PvPI Suspected ADR Format (IPC Guidelines)
B2B Trade & PCD Allotment

Ethical PCD Pharma Franchise & District Monopoly Rights

One district, one partner, fixed margins. Exclusive stamp-paper rights for licensed stockists — terms upfront.

District monopoly
1 deed
Stamp-paper deed. No infiltration or sub-stockist discounting in your territory.
Chemist margin (PTR)
20%
Retailer margin, within DPCO 2013 / NPPA ceilings.
Stockist margin (PTS)
10%
Stockist margin with full GST input credit.
Depot dispatch
24–48h
V-Trans / Safechem from Kolkata depot, plus promo kit.
  1. Send credentials

    Name, phone, licence, territory.

  2. Rate card in 24h

    Availability check plus PTR/PTS rates and MOQs.

  3. Sign & lock

    Stamp-paper deed. The district is yours.

Check your district

Availability check plus confidential rates within 24 hours.

Contact
Territory & range
Licence

Replies within 24 hours · Trade enquiries only